Ardent Health, Inc. 8-K

What Happened
Ardent Health, Inc. (ARDT) filed an 8-K on May 26, 2026 reporting results from its Annual Meeting held May 20, 2026. A total of 98,778,826 shares were represented in person or by proxy out of 143,095,662 shares outstanding and entitled to vote as of the record date. All 11 director nominees were elected to the Board. Stockholders also approved the advisory "say-on-pay" vote and ratified Ernst & Young LLP as the Company’s independent auditor for fiscal 2026.

Key Details

• Shares represented: 98,778,826 of 143,095,662 outstanding shares.
• Directors elected (For / Withhold / Broker Non-Votes 7,200,070):
  • Mark Sotir: 90,717,572 For / 861,184 Withhold
  • Martin J. Bonick: 91,240,732 For / 338,024 Withhold
  • Peter Bulgarelli: 91,267,887 For / 310,869 Withhold
  • Peter Bynoe: 87,141,918 For / 4,436,838 Withhold
  • Suzanne Campion: 91,271,694 For / 307,062 Withhold
  • Robert A. DeMichiei: 91,243,922 For / 334,834 Withhold
  • William Goodyear: 91,243,902 For / 334,854 Withhold
  • Ellen Havdala: 86,273,698 For / 5,305,058 Withhold
  • Edmondo Robinson: 91,328,193 For / 250,563 Withhold
  • Rahul Sen: 79,335,440 For / 12,243,316 Withhold
  • Rob Webb: 91,362,871 For / 215,885 Withhold
• Advisory approval of executive compensation (say-on-pay): 91,093,535 For / 300,746 Against / 184,475 Abstentions (7,200,070 broker non-votes).
• Auditor ratification: Ernst & Young LLP ratified as auditor for 2026 — 97,852,830 For / 918,233 Against / 7,763 Abstentions.

Why It Matters
These results confirm the Company's board and governance direction through 2026: all director nominees were elected and shareholders signaled strong support for executive compensation via the non-binding say-on-pay vote. Ratification of Ernst & Young maintains continuity of the Company’s external audit for the coming fiscal year. Investors should note the vote totals for certain directors (e.g., Rahul Sen, Ellen Havdala, Peter Bynoe) that show higher withhold counts, which can be useful context for governance engagement or future proxy discussions.